CD133 expression is correlated with poor prognosis in colorectal cancer

Hepato-Gastroenterology

Volumn 61, Issue 134, 2014, Pages 1563-1567

  Kashihara, Hideya ^a   Shimada, Mitsuo ^a   Kurita, Nobuhiro ^a   Iwata, Takashi ^a   Sato, Hirohiko ^a   Yoshikawa, Kozo ^a   Higashijima, Jun ^a   Chikakiyo, Motoya ^a   Nishi, Masaaki ^a   Matsumoto, Noriko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CD133; Colorectal cancer; Poor prognosis

Indexed keywords

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; CHEMISTRY; CHI SQUARE DISTRIBUTION; COLON RESECTION; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; ANTIGENS, CD; CHI-SQUARE DISTRIBUTION; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PEPTIDES; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84906963334     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge13657     Document Type: Article

References (20)

1. Ahmedin Jemal DVM PhD, Rebecca Siegel MPH, Elizabeth Ward PhD, Taylor Murray, Jiaquan Xu, Carol Smigal, MPH and Michael J Thun MD MS : Cancer statistics. CA Cancer J Clinic 56: 106-130, 2006.
2. Bonnet D and Dick J E: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med 3: 730-737, 1997. (Pubitemid 27298715)
3. Pardal R, Clarke M F and Morrison S J: Applying the principles of stem-cell biology to cancer. Nature Rev Cancer 3: 895-902, 2003. (Pubitemid 37500174)
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004. (Pubitemid 39551674)
5. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-10, 2007. (Pubitemid 46067310)
6. Ricci-Vitiani L, Lombardi DC, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R: Identification and expansion of human colon cancer-initiating cells. Nature 445:111-5, 2007. (Pubitemid 46067311)
7. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S and Rhim JS: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67: 3153-61, 2007. (Pubitemid 46724852)
8. Shimada M, Sugimoto K, Iwahashi S, Utsunomiya T, Morine Y, Imura S and Ikemoto T: CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol 45: 896-902, 2010.
9. Horst D, Kriegl L, Engel J, Kirchner T and Jung A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 99: 1285-9, 2008.
10. Colorectal Cancer Study Group of Japan: Japanese Classification of Colorectal Carcinoma 2nd English ed. Tokyo Kanehara, 2009.
11. Becker L, Huang Q and Mashimo H: Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. ScientificWorld Journal 8: 1168-76, 2008.
12. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T and Takao S: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 98:1389-97,2008. (Pubitemid 351543575)
13. Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM and Carter PJ: CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 99:100-9, 2008. (Pubitemid 351920235)
14. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-23, 2007. (Pubitemid 47355323)
15. Miraglia S, Godfrey W, Yin AH, Atkins K, Wamke R, Holden JT, Bray RA, Waller EK, Buck DW: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 15; 90(12): 5013-21, 1997.
16. Corbeil D, Röper K, Hellwig A, Tavian M, Miraglia S, Watt SM, Simmons PJ, Peault B, Buck DW and Huttner WB: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 25; 275(8): 5512-20, 2000.
17. Mizrak D, Brittan M and Alison M.R: CD133: molecule of the moment J Pathol. 214(1): 3-9, 2008.
18. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP and Stassi G. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 11;1(4): 389-402, 2007.
19. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA and Allan AL: High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med Vol 13 No8B: 2236-2252, 2009.
20. Yu JW, Zhang P, Wu JG, Wu SH, Li XQ, Wang ST, Lu RQ, Ni XC and Jiang BJ: Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocarcinoma. J Exp Clin Cancer Res, 29: 141, 2010.